Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0540

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant Dimeglumine (NDC 67184-0540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of FOSAPREPITANT DIMEGLUMINE shown as molecular diagrams representing the active ingredient and its associated dimethylglucamine moiety.*

FDA Label Image

Principal Display Panel (150 mg Vial Label)

Fosaprepitant for Injection vial label, 150 mg per vial, sterile lyophilized powder for intravenous use. The label includes storage instructions, single-dose vial notice to discard unused portion, and manufacturer information for Qilu Pharmaceutical Co., Ltd. The label also features barcode, lot, expiration date, and GTIN placeholders.*

FDA Label Image

Principal Display Panel (150 mg Carton Label)

Packaging label for Fosaprepitant for Injection, 150 mg per vial, a lyophilized powder for intravenous injection. The label details reconstitution instructions with 5 mL of 0.9% sodium chloride and specifies single-dose vial use with discard of unused portion. It notes storage between 2° to 8°C and stability of reconstituted solution for 24 hours at room temperature or below. Manufacturer is Qilu Pharmaceutical Co., Ltd., Haikou, China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.